Health economic measures in schizophrenia research

British Journal of Psychiatry

Volumn 191, Issue SUPPL. 50, 2007, Pages

  McCrone, Paul ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; ECONOMICS; FEMALE; HEALTH CARE COST; MALE; PSYCHOLOGICAL ASPECT; STATISTICS;

NEUROLEPTIC AGENT;

ANTIPSYCHOTIC AGENTS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 34547616657     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.191.50.s42     Document Type: Review

References (18)

1. Andlin-Sobocki, P. & Rössler, W. (2005) Cost of psychotic disorders in Europe. European Journal of Neurology, 12 (suppl. 1), 74-77.
2. Beecham, J. & Knapp, M. (2001) Costing psychiatric interventions. In Measuring Mental Health Needs (2nd edn) (ed. G. Thornicroft), pp. 200-224. Gaskell
3. Burns, T., Knapp, M., Catty, J., et al (2001) Home treatment for mental health problems: a systematic review. Health Technology Assessment, 5, 1-139.
4. Byford, S. Fiander, M., Torgerson, D. J., et al (2000) Cost-effectiveness of intensive v. standard case management for severe psychotic illness: UK700 case management trial. British Journal of Psychiatry, 176, 537-543.
5. Byford, S., McCrone, P. & Barrett, B. (2003) Developments in the quantity and quality of economic evaluations in mental health. Current Opinion in Psychiatry, 16, 703-707.
6. Chisholm, D., Healey, A. & Knapp, M. R. J. (1997) QALYs and mental health care. Social Psychiatry and Psychiatric Epidemiology, 32, 68-75.
7. Curtis, L. & Netten, A. (2006) Unit Costs of Health and Social Care. Personal Social Services Research Unit.
8. Dolan, P., Gudex, C., Kind, P., et al (1995) A Social Tariff for EuroQol: Results from a UK General Population Survey. Centre for Health Economics, University of York.
9. Knapp, M., Chisholm, D., Leese, M., et al (2002) Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. Acta Psychiatrica Scandinavica, 105, 42-54.
10. Knapp, M., Mangalore, R. & Simon, J. (2004) The global costs of schizophrenia. Schizophrenia Bulletin, 30, 279-293.
11. McCrone, P. & Weich, S. (1996) Mental health care costs: paucity of measurement. Social Psychiatry and Psychiatric Epidemiology, 31, 70-77.
12. McCrone, P., Thornicroft, G., Phelan, M., et al (1998) Utilisation and costs of community mental health services. PRiSM Psychosis Study. 5. British Journal of Psychiatry, 173, 391-398.
13. McGlashan, T. H. (1999) Duration of untreated psychosis in first episode schizophrenia: marker or determinant of course, Biological Psychiatry, 46, 899-907.
14. Rosenheck, R., Cramer, J., Xu, W., et al (1998) Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Health Services Research, 33, 1237-1261.
15. Sevy, S., Nathanson, K., Schechter, C., et al (2001) Contingency valuation and preferences of health states associated with side effects of antipsychotic medications in schizophrenia. Schizophrenia Bulletin, 27, 643-652.
16. Singh, S. P. (2007) Outcome measures in early psychosis. Relevance of duration of untreated psychosis. British Journal of Psychiatry, 191 (suppl. 50), s58-s63.
17. Weisbrod, B. A., Test, M. A. & Stein., L. I. (1980) Alternative to mental hospital treatment: II. Economic benefit-cost analysis. Archives of General Psychiatry, 37, 400-405.
18. Williams, A. (1995) The Role of the EuroQoL Instrument in QALY Calculations. Centre for Health Economics, University of York.